Soft Tissue Tumor Without Neurofibromatosis Type 1 With Histopathological Suspicion of Atypical Neurofibromatous Neoplasm of Uncertain Biological Potential (ANNUBP).
Tsuchie H, Nagasawa H, Nanjyo H, Miyakoshi N.
Cureus. 2023 Apr 27;15(4):e38187. doi: 10.7759/cureus.38187. eCollection 2023 Apr.
Atypical "Sclerosing" Osteoblastic Neoplasm: A Tumor of Intermediate Biological Potential Between Usual Osteoblastoma and Conventional Osteosarcoma.
McHugh KE, Reith JD, Lucas DR, Emory CL, Mesko NW, Kilpatrick SE.
Am J Surg Pathol. 2019 May;43(5):610-617. doi: 10.1097/PAS.0000000000001236.
Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
Rekhi B, Verma V, Gulia A, Jambhekar NA, Desai S, Juvekar SL, Bajpai J, Puri A.
Pathol Oncol Res. 2017 Jan;23(1):157-164. doi: 10.1007/s12253-016-0123-0. Epub 2016 Oct 8.
Birmingham atypical cartilaginous tumour imaging protocol (BACTIP) revisited.
Davies AM, Patel A, Azzopardi C, James S, Botchu R.
Clin Radiol. 2025 Apr;83:106837. doi: 10.1016/j.crad.2025.106837. Epub 2025 Feb 5.
[Palliative demolitive surgery].
Caldarola L, Badellino F, Santoro L, Cardone B.
Minerva Med. 1975 May 9;66(35):1668-82.
[Primary intermediate hemangioendothelioma of bone: a study of 5 cases].
Zhang HZ, Jiang ZM, Zhou J, Yang SX, Fan QH, Tan YS, Wang XL.
Zhonghua Bing Li Xue Za Zhi. 2012 Jan;41(1):39-43.
[Cytogenetic changes in low grade central osteosarcomas].
Werner M, Rieck J, Delling G.
Verh Dtsch Ges Pathol. 1998;82:189-94.
[The Seidel humeral nail in limited indications: pathological fractures, delayed union, pseudarthrosis and reconstruction].
Pietu G, Letenneur J, Bourgade M.
Acta Orthop Belg. 1994;60(2):187-93.
Approach to the medically ill borderline patient: a case study.
Fitzgibbon ML, Barbuto J.
Psychol Rep. 1989 Dec;65(3 Pt 2):1091-6. doi: 10.2466/pr0.1989.65.3f.1091.
